Pressure Biosciences Alpha and Beta Analysis
| PBIODelisted Stock | USD 0.49 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Pressure Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Pressure Biosciences over a specified time horizon. Remember, high Pressure Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Pressure Biosciences' market risk premium analysis include:
Beta (0.51) | Alpha (0.88) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Pressure |
Pressure Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Pressure Biosciences market risk premium is the additional return an investor will receive from holding Pressure Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pressure Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Pressure Biosciences' performance over market.| α | -0.88 | β | -0.51 |
Pressure Biosciences Fundamentals Vs Peers
Comparing Pressure Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pressure Biosciences' direct or indirect competition across all of the common fundamentals between Pressure Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pressure Biosciences or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Pressure Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Pressure Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Pressure Biosciences to competition |
| Fundamentals | Pressure Biosciences | Peer Average |
| Return On Asset | -0.93 | -0.14 |
| Operating Margin | (3.18) % | (5.51) % |
| Current Valuation | 33.23 M | 16.62 B |
| Shares Outstanding | 11.07 M | 571.82 M |
| Shares Owned By Insiders | 1.27 % | 10.09 % |
| Shares Owned By Institutions | 0.05 % | 39.21 % |
| Number Of Shares Shorted | 6.34 K | 4.71 M |
Pressure Biosciences Opportunities
Pressure Biosciences Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
About Pressure Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Pressure or other otcs. Alpha measures the amount that position in Pressure Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Pressure Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Pressure Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pressure Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Pressure Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Pressure Biosciences. Please utilize our Beneish M Score to check the likelihood of Pressure Biosciences' management manipulating its earnings.
| 10th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Pressure Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Pressure OTC Stock
If you are still planning to invest in Pressure Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pressure Biosciences' history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |